×
Close
註冊
登入
主页
医学图书S馆
医学图书D馆
活动
Upcoming Events
Past Events
用户工具
用户指南
语言
English
中文/ Chinese
French
Português
Español
Arabic
Russian
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
分类
Endocrinology, Metabolism & Nutrition
23582
Global Medical University
5020
Allergy
1783
Anatomy & Morphology
1527
Andrology
414
Anesthesia & Intensive Care
1214
Anesthesiology
5442
Audiology & Speech-Language Pathology
332
Behavioral Sciences
100
Biochemical Research Methods
6818
Biochemistry & Molecular Biology
29335
Biodiversity Conservation
288
Biology
8218
Biophysics
8099
Biotechnology & Applied Microbiology
8197
Cardiac & Cardiovascular Systems
30752
Cardiovascular & Respiratory Systems
1391
Cell & Tissue Engineering
654
Cell Biology
10825
Chemistry, Analytical
4216
Chemistry, Applied
11003
Chemistry, Medicinal
8487
Chemistry, Multidisciplinary
18503
Clinical Immunology & Infectious Disease
442
Clinical Medicine
8751
Clinical Neurology
16238
Clinical Psychology & Psychiatry
1298
Critical Care Medicine
3153
Dentistry, Oral Surgery & Medicine
12959
Dermatology
7601
Developmental Biology
6915
Ecology
645
Education, Scientific Disciplines
1886
Emergency Medicine
3981
Engineering, Biomedical
3586
Entomology
425
Environmental Medicine & Public Health
4623
Evolutionary Biology
254
Gastroenterology & Hepatology
11883
General & Internal Medicine
6948
Genetics & Heredity
14711
Geriatrics & Gerontology
5022
Gerontology
338
Health Care Sciences & Services
15636
Health Policy & Services
594
Hematology
5456
Immunology
24666
Infectious Diseases
13671
Integrative & Complementary Medicine
2758
Medical Ethics
1146
Medical Informatics
2117
Medical Laboratory Technology
433
Medicine, General & Internal
44233
Medicine, Legal
493
Medicine, Research & Experimental
17436
Microbiology
22778
Mycology
0
Nanoscience & Nanotechnology
5039
Neuroimaging
1293
Neurology
4396
Neurosciences
38942
Nursing
9355
Nutrition & Dietetics
7802
Obstetrics & Gynecology
8102
Oncology
51594
Ophthalmology
9493
Optics
4025
Orthopedics
11367
Orthopedics, Rehabilitation & Sports Medicine
1729
Otolaryngology
1505
Otorhinolaryngology
4791
Parasitology
1040
Pathology
4888
Pediatrics
21065
Peripheral Vascular Disease
4693
Pharmacology & Pharmacy
33972
Pharmacology/Toxicology
12027
Physiology
8875
Polymer Science
539
Primary Health Care
795
Psychiatry
18891
Psychology
5053
Psychology, Applied
92
Psychology, Biological
335
Psychology, Clinical
785
Psychology, Developmental
222
Psychology, Educational
149
Psychology, Experimental
122
Psychology, Mathematical
0
Psychology, Multidisciplinary
1590
Psychology, Psychoanalysis
41
Psychology, Social
114
Public Health & Health Care Science
2227
Public, Environmental & Occupational Health
26926
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12032
Radiology, Nuclear Medicine & Medical Imaging
7772
Rehabilitation
2967
Remote Sensing
0
Reproductive Biology
2745
Reproductive Medicine
1131
Research/Laboratory Medicine & Medical Technology
3872
Respiratory System
7101
Rheumatology
5751
Social Sciences, Biomedical
1176
Substance Abuse
2676
Surgery
33275
Toxicology
4241
Transplantation
927
Tropical Medicine
314
Urology & Nephrology
12745
Veterinary Sciences
35
Virology
2383
Zoology
0
渠道
DIABETES OBESITY & METABOLISM
293
NEJM Endocrinology
9
Medrxiv - Endocrinology Medrxiv
410
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
472
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
173
BIOLOGY OF SEX DIFFERENCES
182
BMJ OPEN DIABETES RESEARCH & CARE
352
BONE
0
CALCIFIED TISSUE INTERNATIONAL
323
CARDIOVASCULAR DIABETOLOGY
627
CURRENT DIABETES REPORTS
144
CURRENT OBESITY REPORTS
112
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
167
CURRENT OPINION IN LIPIDOLOGY
121
CURRENT OSTEOPOROSIS REPORTS
161
DIABETES
134
DIABETES & METABOLISM
183
DIABETES & METABOLISM JOURNAL
40
DIABETES CARE
194
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
928
DIABETES RESEARCH AND CLINICAL PRACTICE
0
DIABETES-METABOLISM RESEARCH AND REVIEWS
105
DIABETIC MEDICINE
215
DIABETOLOGIA
527
ENDOCRINE
622
ENDOCRINE PATHOLOGY
132
ENDOCRINE PRACTICE
615
EUROPEAN THYROID JOURNAL
19
FRONTIERS IN ENDOCRINOLOGY
5681
HORMONES AND BEHAVIOR
308
JOURNAL OF BONE AND MINERAL RESEARCH
173
JOURNAL OF DIABETES
101
JOURNAL OF DIABETES INVESTIGATION
260
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
607
JOURNAL OF HUMAN NUTRITION AND DIETETICS
112
JOURNAL OF NEUROENDOCRINOLOGY
115
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
252
LANCET DIABETES & ENDOCRINOLOGY
16
METABOLISM-CLINICAL AND EXPERIMENTAL
18
MOLECULAR METABOLISM
510
NATURE REVIEWS ENDOCRINOLOGY
424
NEUROENDOCRINOLOGY
149
NUTRITION & DIABETES
100
OBESITY
151
OBESITY REVIEWS
130
PEDIATRIC DIABETES
87
PSYCHONEUROENDOCRINOLOGY
0
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
34
ARCHIVES OF ENDOCRINOLOGY METABOLISM
0
CLINICAL ENDOCRINOLOGY
179
DIABETES & VASCULAR DISEASE RESEARCH
16
DIABETOLOGY & METABOLIC SYNDROME
499
ENDOCRINOLOGIA DIABETES Y NUTRICION
377
GENERAL AND COMPARATIVE ENDOCRINOLOGY
0
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
152
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
139
JOURNAL OF CLINICAL DENSITOMETRY
226
JOURNAL OF DIABETES AND ITS COMPLICATIONS
417
NEUROIMMUNOMODULATION
83
OBESITY FACTS
160
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
378
WORLD REVIEW OF NUTRITION AND DIETETICS
30
HORMONE AND METABOLIC RESEARCH
312
NEUROPEPTIDES
139
THYROID RESEARCH
88
REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL
44
BRITISH JOURNAL OF DIABETES
114
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES
20
CLINICAL OBESITY
44
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM
30
DIABETOLOGY INTERNATIONAL
175
JOURNAL OF DIABETES AND METABOLIC DISORDERS
521
JOURNAL OF DIABETOLOGY
126
JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES
176
OBESITY SCIENCE & PRACTICE
87
PITUITARY
261
OSTEOPOROSIS INTERNATIONAL
568
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
232
DIABETES THERAPY
421
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
243
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
323
METABOLIC BRAIN DISEASE
514
SCI时时刷
search
全部
推荐
+
Effects of a six‐month low‐carbohydrate diet on glycemic control, body composition and cardiovascular risk factors in patients with type 2 diabetes: an open‐label RCT
Abstract Aims To investigate the efficacy and safety of a non-calorie-restricted low-carbohydrate diet (LCD) on glycemic c...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post‐hoc analysis from the REWIND Randomized Trial
Abstract Aims Diabetes mellitus is an independent risk factor for atrial fibrillation or atrial flutter (atrial arrythmia,...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Reduction of clinically important low glucose excursions with a long‐term implantable continuous glucose monitoring (CGM) system in adults with type 1 diabetes prone to hypoglycemia. France Adoption randomized clinical trial
Abstract Aim This trial assessed the outcomes on glucose control of the implantable Eversense real-time continuous glucose...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Acute effects of linagliptin on intact and total GLP‐1 and GIP levels in insulin‐dependent type 2 diabetic patients with and without moderate renal impairment
Abstract Aims Impaired renal function is a frequent complication in patients with type 2 diabetes mellitus (T2DM). The goa...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Understanding the clinical implications of differences between GMI and HbA1c
Abstract Laboratory measured glycosylated hemoglobin (HbA1c) is the gold standard for assessing glycemic control in people...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Quételet (Body Mass) Index and Effects of Dapagliflozin in CKD
Abstract Aims This post-hoc analysis of DAPA-CKD (NCT03036150) assessed the effects of dapagliflozin in patients with chro...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of high‐dose GLP‐1, GLP‐1/GIP and GLP‐1/glucagon receptor agonists in type 2 diabetes
Abstract Background GLP-1 receptor agonists (GLP-1 RAs) have become agents of choice for people with type 2 diabetes (T2D)...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of imeglimin add‐on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double‐blind, placebo‐controlled phase 3 trial with a 36‐week open‐label extension period
Abstract Aims To evaluate the efficacy and safety of imeglimin for up to 52 weeks as combination therapy with insul...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Combined SGLT‐2 and ACE inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial
ABSTRACT Aims Sodium glucose co-transporter-2 inhibitors (SGLT-2i) improve cardiorenal outcomes in chronic kidney disease ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
ABSTRACT Aims Bempedoic acid inhibits ATP-citrate lyase (ACL), an enzyme in the cholesterol synthesis pathway. Mendelian r...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin‐R with the US‐licensed Humulin® R formulation in healthy subjects: Results from the RHINE‐1 (Recombinant Human INsulin Equivalence‐1) study
Abstract Aims The aim of RHINE-1, a double-blind, randomized, two-treatment, two-period, two-sequence crossover study, was...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow‐up (DPV) database
Abstract Aim To assess the prevalence of elevated liver enzymes and associated diabetes-related comorbidities in type 2 di...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Improving beta‐cell secretory function and glycaemia in young‐onset type 2 diabetes: A pilot, 12‐month, randomized trial of a novel, continuous glucose monitor‐guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide
1 BACKGROUND Young-onset type 2 diabetes (YT2D) is characterized by poorer glycaemic control, a higher ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52‐week, open‐label, multicentre phase 3 trial
Abstract Aim To evaluate the safety and efficacy of imeglimin for 52 weeks as monotherapy or combination therapy wi...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial
1 INTRODUCTION The prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 25% in both...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes
Abstract Aims The glucagon-like peptide-1 analogue, semaglutide, has been co-formulated with the absorption enhancer, sodi...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Pushing the limits of insulin delivery 100 years later: A Case Study of a Race Across Canada
This article has been accepted for publication and undergone full peer review but has not been through the co...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Real‐world data of 12‐month adjunct sodium‐glucose co‐transporter‐2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis
1 INTRODUCTION Sodium-glucose co-transporter-2 inhibitors (SGLT2is) represent a class of oral antidiabe...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Where can you wear your libre? Using the FreeStyle Libre Continuous Glucose Monitor on Alternative Sites
Abstract Aims Subcutaneous continuous glucose monitoring (CGMS) has transformed management of Type 1 diabetes (T1DM). The ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
SGLT‐2 inhibitor for type 1 diabetes ‐ not any more?
This article has been accepted for publication and undergone full peer review but has not been through the co...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
The relationship between hypoglycaemia and glucose variability in type 1 diabetes
1 INTRODUCTION Hypoglycaemia is a considerable barrier to intensified blood glucose management in type ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Disparity in the rural‐urban distribution of clinical trial sites used in studies cited by diabetes treatment guidelines
1 INTRODUCTION The prevalence of diabetes and the associated complications are higher in rural areas in...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials
Abstract Aim To investigate the association between treatment with dulaglutide and glycaemic variability (GV) in adult pat...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
Abstract Aims To conduct a pooled analysis to assess the performance of intermittently scanned continuous glucose monitori...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Metabolically healthy obesity and cardiovascular events: A risk of obesity
Corresponding Author Tomoyuki Kawada MD & PhD Departme...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes and Non‐Alcoholic Fatty Liver Disease: A Multicenter, Double‐blind, Randomized, Comparative trial
Corresponding Author Byung-Wan Lee MD, PhD Division of End...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Cost‐Effectiveness of Second‐Line Empagliflozin versus Liraglutide for Type 2 Diabetes in the United States
Abstract Aims To estimate the cost-effectiveness of sequential use of the sodium-glucose co-transporter 2 inhibitor empagl...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects
Corresponding Author Soo Lim MD Department of Internal Med...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
Abstract Aims The sodium-glucose co-transporter-2 inhibitor empagliflozin reduced the total burden of cardiovascular morta...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population‐based analysis between 2010‐2020
Abstract Aim To examine trends in basal insulin prescribing in older adults with CKD. Materials and methods We conducted a...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin